Dublin, Nov. 12, 2021 (GLOBE NEWSWIRE) -- The "Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure (ART (IVF,ICSI, Surrogate), Insemination, (Laparoscopy, Hysteroscopy), Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Research) - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
The global infertility treatment market size is projected to reach USD 2.2 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 8.1 % during the forecast period.
Factors such as decline in the fertility rates worldwide, increase adoption of different infertility procedures, rising number of fertility clinics worldwide, rise in public & private investments and presence of advanced infertility treatment products in the market are anticipated to boost the growth of the market.
The recent COVID-19 global pandemic has also impacted the infertility treatment market. Logistical issues, managing patients with the disease, prioritizing patients with comorbidities and pre-existing conditions, and protecting public & hospital frontline workers from exposure to the COVID-19 infection are the major challenges faced by healthcare systems across the globe.
One in six reproductive-aged couples experiences infertility, and many turn to treatments such as intrauterine insemination (IUI) and in vitro fertilization (IVF), which require in-person appointments to complete. In India, 30 lakh people seek infertility treatment every year, but only 5 lakh people undergo IVF/intrauterine insemination (IUI) procedures.
During the COVID-19 pandemic, a 90% drop was observed in the number of people undergoing IVF cycles. The spread of COVID-19 has not only impacted fertility clinics owing to the cancellation of IVF treatments but has also impacted fertility decisions among couples who were opting for IVF treatment before the pandemic.
The equipment to capture the largest share in infertility treatment market, by products during the forecast period.
The equipment segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the technological advancements and presence of well-established players with strong product portfolio. Along with this growing focus of players towards base expansion through adopting various strategies such as new equipment launch, showcase across the globe is likely to contribute towards the growth of the segment.
The assisted reproductive technology (ART) to capture the largest market share of infertility treatment market, by the procedure in 2021.
The assisted reproductive technology segment captured the largest share of the infertility treatment market procedures during the forecast period. The growing awareness of the presence of ART, rise in success rate of this procedure and growing worldwide acceptance of ART is likely to boost the growth of the segment.
The female infertility treatment segment commanded for the largest share of the infertility treatment market, by patient type, in 2021
The decreasing rates of fertility among females, growing availability of various fertility treatment options, and the increasing number of fertility centers across the globe are driving the growth of the female infertility treatment market.
The fertility centers segment accounted for the largest share of the infertility treatment market, by end user, in 2021
The rising government initiatives to establish fertility clinics, initiatives taken by large international healthcare providers to establish fertility centers, and the increasing popularity of IVF & ICSI treatment globally are some of the factors likely to contribute towards the rapid growth of the segment.
The Asia Pacific market to grow at the highest CAGR during the forecast period.
The infertility treatment market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Increase in the awareness of availability of infertility treatment procedures, growing fertility centers in the region, rising healthcare expenditures, increasing patient population, growing medical tourism, improving healthcare expenditure on infertility treatment, and initiatives by the government to increase the accessibility of the infertility treatment in the emerging nations.
As of 2020, The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), FUJIFILM Irvine Scientific (US), Kitazato Corporation (Japan), and Hamilton Thorne Ltd. (US) were the leading players in this market.
Other prominent players operating in the infertility treatment market include Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), The Baker Company, Inc. (US), Rocket Medical plc (UK), IHMedical A/S (Denmark), MedGyn Products, Inc. (US), and ZEISS Group (Germany).
Declining Fertility Rate and Rising Number of Fertility Clinics Worldwide to Drive Market Growth
Media & Consumables Segment to Register the Highest Growth in the Infertility Treatment Market During the Forecast Period
Assisted Reproductive Technology is the Largest Procedure Segment of the Infertility Treatment Market
Male Infertility Treatment Segment to Witness the Highest Growth in the Forecast Period
Fertility Centers are the Largest End-users of Infertility Treatment Products
Equipment Segment is Expected to Account for the Largest Share of the APAC Infertility Treatment Market in 2021
APAC Market to Witness the Highest Growth During the Forecast Period (2021-2026)
Declining Fertility Rate
Rising Number of Fertility Clinics Worldwide
Advancements in Infertility Treatment Devices
Increasing Use of Time-Lapse Technology Worldwide
Increasing Public-Private Investments, Funds, and Grants
High Costs Associated with Assisted Reproductive Technology in Developed Markets
Unsupportive Government Regulations
Growth Opportunities in Emerging Markets
Improving Healthcare Infrastructure
Increasing Medical Tourism due to Low Treatment Costs
Use of Fertility Treatment Options by Single Parents and Same-Sex Couples
Concerns Related to Art Procedures
Reduced Efficacy Among Older Women
The Cooper Companies Inc.
Thermo Fisher Scientific
Hamilton Thorne Ltd.
Esco Micro Pte. Ltd.
Fujifilm Irvine Scientific
The Baker Company, Inc.
Rocket Medical plc
Medgyn Products, Inc.
Nidacon International Ab
Sar Healthline Pvt. Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/xrowie
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900